Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Roland Zuest"'
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
Autor:
Meihui Xu, Roland Zuest, Sumathy Velumani, Farhana Tukijan, Ying Xiu Toh, Ramapraba Appanna, Ern Yu Tan, Daniela Cerny, Paul MacAry, Cheng-I Wang, Katja Fink
Publikováno v:
npj Vaccines, Vol 2, Iss 1, Pp 1-10 (2017)
Dengue: A single vaccine candidate for all strains An antibody-vaccine candidate has been discovered that neutralizes and confers protection against all four strains of dengue virus. Katja Fink, of the Singapore Immunology Network and Nanyang Technol
Externí odkaz:
https://doaj.org/article/d00823a1151b41528cddd99e691c0ef6
Autor:
Ramapraba Appanna, Srinivasan KG, Mei Hui Xu, Ying-Xiu Toh, Sumathy Velumani, Daniel Carbajo, Chia Yin Lee, Roland Zuest, Thavamalar Balakrishnan, Weili Xu, Bernett Lee, Michael Poidinger, Francesca Zolezzi, Yee Sin Leo, Tun Linn Thein, Cheng-I Wang, Katja Fink
Publikováno v:
EBioMedicine, Vol 12, Iss C, Pp 178-188 (2016)
Dengue is endemic in tropical countries worldwide and the four dengue virus serotypes often co-circulate. Infection with one serotype results in high titers of cross-reactive antibodies produced by plasmablasts, protecting temporarily against all ser
Externí odkaz:
https://doaj.org/article/739048db10574895a3c00006602f43d1
Autor:
Cheng-I Wang, Kandhadayar G. Srinivasan, Michael Poidinger, Daniel Carbajo, Francesca Zolezzi, Mei Hui Xu, Sumathy Velumani, Ying-Xiu Toh, Chia Yin Lee, Tun-Linn Thein, Yee Sin Leo, Ramapraba Appanna, Roland Zuest, Katja Fink, Weili Xu, Bernett Lee, Thavamalar Balakrishnan
Publikováno v:
EBioMedicine, Vol 12, Iss C, Pp 178-188 (2016)
EBioMedicine
EBioMedicine
Dengue is endemic in tropical countries worldwide and the four dengue virus serotypes often co-circulate. Infection with one serotype results in high titers of cross-reactive antibodies produced by plasmablasts, protecting temporarily against all ser
Autor:
Meihui Xu, Katja Fink, Ying Xiu Toh, Cheng-I Wang, Roland Zuest, Farhana Tukijan, Ern Yu Tan, Paul A. MacAry, Ramapraba Appanna, Sumathy Velumani, Daniela Cerny
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 3, Iss 1, Pp 1-1 (2018)
npj Vaccines, Vol 3, Iss 1, Pp 1-1 (2018)
A therapy for dengue is still elusive. We describe the neutralizing and protective capacity of a dengue serotype-cross-reactive antibody isolated from the plasmablasts of a patient. Antibody SIgN-3C neutralized all four dengue virus serotypes at nano
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
Autor:
Roland Zuest, Daniela Cerny, Katja Fink, Ying Xiu Toh, Meihui Xu, Ern Yu Tan, Sumathy Velumani, Cheng-I Wang, Paul A. MacAry, Ramapraba Appanna, Farhana Tukijan
Publikováno v:
npj Vaccines, Vol 2, Iss 1, Pp 1-10 (2017)
A therapy for dengue is still elusive. We describe the neutralizing and protective capacity of a dengue serotype-cross-reactive antibody isolated from the plasmablasts of a patient. Antibody SIgN-3C neutralized all four dengue virus serotypes at nano
Autor:
E-De Qin, Yong-Qiang Deng, Xiaofeng Li, Shihua Li, Cheng-Feng Qin, Qibin Leng, Qing Ye, Hui Zhao, Xiaoyu Wang, Xuping Xie, Shun-Ya Zhu, Hong-Jiang Wang, Bo Zhang, Roland Zuest, Pei Yong Shi, Hongping Dong
Publikováno v:
Journal of Virology
Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase(s) to methylate N-7 and 2′- O cap of their RNA; alternatively, they “snatch” host mRNA cap to form the
Autor:
Yee Sin Leo, Solomonraj Wilson, Ramapraba Appanna, Roland Zuest, Thavamalar Balakrishnan, Katja Fink, Tun-Linn Thein, Michael Poidinger, Adrian Ong, Lee Ching Ng, Victor C. Gan, Ying Xiu Toh
Publikováno v:
Frontiers in Immunology
Dengue virus has four serotypes and is endemic globally in tropical countries. Neither a specific treatment nor an approved vaccine is available, and correlates of protection are not established. The standard neutralization assay cannot differentiate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3393f13300d7966f1e24d651c29ebc
https://hdl.handle.net/10356/80938
https://hdl.handle.net/10356/80938
Autor:
Chiea Chuen Khor, Katja Fink, Daniela Cerny, Francesca Zolezzi, Kandhadayar G. Srinivasan, Florent Ginhoux, Duyen Huynh Thi Le, Roland Zuest, Bridget Wills, Lucia Mori, Michael Poidinger, Cameron P. Simmons, Sumathy Velumani, Muzlifah Haniffa
Publikováno v:
Europe PubMed Central
The Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
The family of CD1 molecules is structurally similar to MHC class I molecules, but the 2 protein families mediate fundamentally different immune functions. MHC class I molecules present peptides to T cells, whereas CD1 molecules present lipids to natu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa9ce9a73faed0bf39dec281ec585d7
http://europepmc.org/abstract/med/27484031
http://europepmc.org/abstract/med/27484031